Supercharged immune cells take on tough cancers in early human test
NCT ID NCT05103631
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests a new experimental treatment called CATCH T cells in up to 12 adults with certain solid tumors (like liver cancer or Wilms tumor) that have returned or not responded to standard care. The cells are the patient's own T cells, genetically modified in the lab to recognize a protein called GPC3 on cancer cells and to produce IL15, which helps them survive longer. The main goal is to find a safe dose and watch for side effects, while also checking if the tumors shrink.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CATCH T cells (genetically modified immune cells that target GPC3 and produce IL15)
What this could lead to
If it works, this could point toward a new treatment option for several hard-to-treat solid tumors that have not responded to standard therapy.
What could go wrong
This is a very early (Phase 1) and small (12 patients) trial focused on safety, not effectiveness. The cells may not shrink tumors, and there are risks of serious side effects like cytokine release syndrome.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States